돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1417835생성일: 2026년 10월 26일

Trimethylsilyl isocyanate → 1-(4-Methoxyphenyl)-4-[2-(5-aminocarbonylisochroman-1-yl)ethyl]piperazine

https://huagongshe.com/reaction/1417835

반응식

참여 물질

역할이름HCID투입량
반응물Trimethylsilyl isocyanateHCID 70696—
반응물1-(4-Methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazineHCID 23288744—
반응물HCID 178418306HCID 178418306—
용매TetrahydrofuranHCID 8028—
용매1,4-DioxaneHCID 31275—
생성물1-(4-Methoxyphenyl)-4-[2-(5-aminocarbonylisochroman-1-yl)ethyl]piperazineHCID 23288829—

반응 단계

A mixture of t-butyl lithium (2 eqs, 1.7M in hexane) in THF (2 ml/mmol bromide) is cooled to -78° for 10 minutes before adding the 1-(4-methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine (LXXIV, EXAMPLE 100) in THF (4 ml/mmol) dropwise over 10 minutes. A freshly distilled solution of trimethylsilylisocyanate (1.5 eqs) is added via syringe as a solution in dioxane (4 volume equivalents) at once. After 15 minutes, the cooling bath is removed and the mixture allowed to warm to 20°-25°. The reaction mixture is quenched with ammonium chloride, the organics are removed under reduced pressure, and the aqueous residue is extracted two times with methylene chloride, dried over sodium sulfate, filtered and concentrated. The crude material is purified by flash chromatography on silica gel. In this manner, 1-(4-methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine (LXXIV, EXAMPLE 100, 345 mg) is converted to the corresponding amide, the title compound, mp 185°-186°.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05877317
출처 데이터셋uspto-grants-1999_03
ORD IDord-d878029febda4befa871bebf18ae3d89
출처 메모uspto-grants-1999_03